Dr. Nicholas Siebers

Internal Medicine
Office
8007 Excelsior Dr, 
Madison, WI 
Accepting New Patients
Office
8007 Excelsior Dr, 
Madison, WI 

Overview

Nicholas Siebers is a primary care provider, practicing in Internal Medicine in Madison, Wisconsin. Dr. Siebers is currently accepting new patients.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Internal Medicine

Licenses

Internal Medicine in WI

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
8007 Excelsior Dr, Madison, WI 53717

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 1, Open-label, Study of the Absorption, Metabolism, and Excretion of [14C]-KBP-5074 Following a Single Oral Dose in Healthy Male Subjects
A Phase 1, Open-label, Study of the Absorption, Metabolism, and Excretion of [14C]-KBP-5074 Following a Single Oral Dose in Healthy Male Subjects
Enrollment Status: Completed
Publish Date: December 16, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3841136 in Healthy and Overweight Participants
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3841136 in Healthy and Overweight Participants
Enrollment Status: Completed
Publish Date: April 01, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Bioequivalence Study of Injections of Mirikizumab Solution Using an Investigational 1-mL Pre-Filled Syringe and an Investigational 1-mL Autoinjector in Healthy Participants
A Bioequivalence Study of Injections of Mirikizumab Solution Using an Investigational 1-mL Pre-Filled Syringe and an Investigational 1-mL Autoinjector in Healthy Participants
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects
A Randomized Study to Investigate Injection-Site Pain Following Subcutaneous Injections of 2 Ixekizumab Test Formulations Compared to the Commercial Formulation Using a Pre-filled Syringe in Healthy Subjects
Enrollment Status: Terminated
Publish Date: November 30, 2022
Intervention Type: Biological
Study Phase: Phase 1
An Open-label Trial to Evaluate the Absorption, Metabolism, and Excretion of a Single Dose of [14C]-Tavapadon in Healthy Adult Male Subjects at Steady State
An Open-label Trial to Evaluate the Absorption, Metabolism, and Excretion of a Single Dose of [14C]-Tavapadon in Healthy Adult Male Subjects at Steady State
Enrollment Status: Completed
Publish Date: November 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, 4-Period Cross-Over Study Assessing the Duration of Effect of Lasmiditan on Simulated Driving Performance in Healthy Volunteers
A Phase I, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, 4-Period Cross-Over Study Assessing the Duration of Effect of Lasmiditan on Simulated Driving Performance in Healthy Volunteers
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects
A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects
Enrollment Status: Completed
Publish Date: December 02, 2019
Intervention Type: Drug
Study Phase: Phase 1
Safety, Tolerability, and Pharmacokinetics of Lasmiditan When Co-administered With Topiramate in Healthy Subjects
Safety, Tolerability, and Pharmacokinetics of Lasmiditan When Co-administered With Topiramate in Healthy Subjects
Enrollment Status: Completed
Publish Date: November 27, 2019
Intervention Type: Drug
Study Phase: Phase 1
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Enrollment Status: Completed
Publish Date: November 26, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 8 Less Clinical Trials

7 Total Publications

Pharmacokinetics, metabolism, and excretion of [14C]-valemetostat in healthy male participants, and in vitro plasma protein binding.
Pharmacokinetics, metabolism, and excretion of [14C]-valemetostat in healthy male participants, and in vitro plasma protein binding.
Journal: Cancer chemotherapy and pharmacology
Published: November 01, 2024
Similar Doctors
Neil Binkley
Expertise in
14
conditions
Dr. Neil Binkley
Internal Medicine
Expertise in
14
conditions
Dr. Neil Binkley
Internal Medicine

UW Health Junction RD Medical Center PPM

451 Junction Rd, 
Madison, WI 
 (11.9 miles away)
608-263-5010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Neil Binkley is an Internal Medicine provider in Madison, Wisconsin. Dr. Binkley is highly rated in 14 conditions, according to our data. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Malnutrition, Knee Replacement, and Hip Replacement.

Expertise in
10
conditions
Dr. Anne Traynor
Internal Medicine
Expertise in
10
conditions
Dr. Anne Traynor
Internal Medicine

University Hospital

600 Highland Ave, 
Madison, WI 
 (7.3 miles away)
608-265-1700
Languages Spoken:
English
See accepted insurances

Anne Traynor is an Internal Medicine provider in Madison, Wisconsin. Dr. Traynor is highly rated in 10 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Tubal Ligation.

Expertise in
1
conditions
Dr. Shannon Kenney
Internal Medicine
Expertise in
1
conditions
Dr. Shannon Kenney
Internal Medicine

University Hospital

600 Highland Ave, 
Madison, WI 
 (7.3 miles away)
608-263-0943
Languages Spoken:
English

Shannon Kenney is an Internal Medicine provider in Madison, Wisconsin. Dr. Kenney is highly rated in 1 condition, according to our data. Her top area of expertise is Mononucleosis.

Frequently Asked Questions about Dr. Nicholas Siebers

How do I make an appointment with Dr. Nicholas Siebers?

You can book an appointment with Dr. Nicholas Siebers by calling their office at 608-265-1200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Siebers's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile